BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol 2008; 14(2): 313-317 [PMID: 18186574 DOI: 10.3748/wjg.14.313]
URL: https://www.wjgnet.com/1007-9327/full/v14/i2/313.htm
Number Citing Articles
1
Kouichi Miura, Yuzo Kodama, Sayaka Inokuchi, Bernd Schnabl, Tomonori Aoyama, Hirohide Ohnishi, Jerrold M. Olefsky, David A. Brenner, Ekihiro Seki. Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in MiceGastroenterology 2010; 139(1): 323 doi: 10.1053/j.gastro.2010.03.052
2
Jian Zhang, Chunying Wang, Ji Wang, Fengchi Zhang. Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitisExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5490
3
Domenico Ferro, Francesco Baratta, Daniele Pastori, Nicholas Cocomello, Alessandra Colantoni, Francesco Angelico, Maria Del Ben. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative StressNutrients 2020; 12(9): 2762 doi: 10.3390/nu12092762
4
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut MicrobiotaJournal of Agricultural and Food Chemistry 2019; 67(10): 2754 doi: 10.1021/acs.jafc.9b00080
5
Young Kyung Sung, Geum Youn Gwak, Moon Seok Choi, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee. A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by RepairGut and Liver 2012; 6(4): 520 doi: 10.5009/gnl.2012.6.4.520
6
Vivian Mota GUIMARÃES, Virgínia Nascimento SANTOS, Patrícia Souza de Almeida BORGES, João Luiz Rodrigues DE FARIAS, Penelope GRILLO, Edison Roberto PARISE. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSISArquivos de Gastroenterologia 2020; 57(4): 471 doi: 10.1590/s0004-2803.202000000-82
7
Takaomi Kessoku, Takashi Kobayashi, Kento Imajo, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Yuji Ogawa, Shingo Kato, Takuma Higurashi, Kunihiro Hosono, Masato Yoneda, Takayuki Okamoto, Haruki Usuda, Koichiro Wada, Noritoshi Kobayashi, Satoru Saito, Atsushi Nakajima. Endotoxins and Non-Alcoholic Fatty Liver DiseaseFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.770986
8
Yoon Seok Roh, Jong Won Kim, Surim Park, Changho Shon, Sokho Kim, Seong Kug Eo, Jung Kee Kwon, Chae Woong Lim, Bumseok Kim. Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in MiceThe American Journal of Pathology 2018; 188(11): 2574 doi: 10.1016/j.ajpath.2018.07.011
9
Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for <i>Clostridioides difficile</i> infectionWorld Journal of Hepatology 2021; 13(11): 1777-1790 doi: 10.4254/wjh.v13.i11.1777
10
Phillipp Hartmann, Bernd Schnabl. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease 2021; 41(01): 087 doi: 10.1055/s-0040-1719174
11
Li-Jian Chen, Jie-Tao He, Ming Pan, Jia-Li Liu, Kai-Kai Zhang, Jia-Hao Li, Li-Bin Wang, Ling-Ling Xu, Yu-Kui Chen, Qin-Yao Zhang, Dong-Ri Li, Jing-Tao Xu, Xiao-Li Xie. Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 AxisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.716703
12
Johanna Iturrino, Madhusudan Grover. Practical Gastroenterology and Hepatology Board Review Toolkit2016; : 285 doi: 10.1002/9781119127437.ch47
13
Shunyi Li, Kyosuke Yakabe, Khadijah Zai, Yiwei Liu, Akihiro Kishimura, Koji Hase, Yun-Gi Kim, Takeshi Mori, Yoshiki Katayama. Specific adsorption of a β-lactam antibiotic in vivo by an anion-exchange resin for protection of the intestinal microbiotaBiomaterials Science 2021; 9(21): 7219 doi: 10.1039/D1BM00958C
14
Takaomi Kessoku, Takashi Kobayashi, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Michihiro Iwaki, Anna Ozaki, Yuki Kasai, Asako Nogami, Yasushi Honda, Yuji Ogawa, Shingo Kato, Kento Imajo, Takuma Higurashi, Kunihiro Hosono, Masato Yoneda, Haruki Usuda, Koichiro Wada, Satoru Saito, Atsushi Nakajima. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic TargetInternational Journal of Molecular Sciences 2021; 22(15): 8161 doi: 10.3390/ijms22158161
15
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Ryota Masuzaki, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2020; 21(4): 1525 doi: 10.3390/ijms21041525
16
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari. The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver DiseaseNutrients 2014; 6(12): 5583 doi: 10.3390/nu6125583
17
Ruiting Han, Junli Ma, Houkai Li. Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiotaFrontiers of Medicine 2018; 12(6): 645 doi: 10.1007/s11684-018-0645-9
18
Elena Ermolenko. Effects of autoprobiotic consortium and fecal transplant on the digestive system and intestinal microbiota in the correction of experimental dysbiosisGastroenterology & Hepatology: Open Access 2020; 11(6): 198 doi: 10.15406/ghoa.2020.11.00440
19
Yoon Seok Roh, Ekihiro Seki. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesisJournal of Gastroenterology and Hepatology 2013; 28: 38 doi: 10.1111/jgh.12019
20
Mustafa Cengiz, Seren Ozenirler, Sehri Elbeg. Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosisJournal of Gastroenterology and Hepatology 2015; 30(7): 1190 doi: 10.1111/jgh.12924
21
Kento Imajo, Masato Yoneda, Yuji Ogawa, Koichiro Wada, Atsushi Nakajima. Microbiota and nonalcoholic steatohepatitisSeminars in Immunopathology 2014; 36(1): 115 doi: 10.1007/s00281-013-0404-6
22
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Probiotics for dietary management of non-alcoholic fatty liver diseaseEnvironmental Chemistry Letters 2019; 17(4): 1553 doi: 10.1007/s10311-019-00896-8
23
Antonio Tursi, Walter Elisei, Gian Marco Giorgetti, Giovanni Brandimarte, Fabio Aiello. Complications in Celiac Disease Under Gluten-Free DietDigestive Diseases and Sciences 2009; 54(10): 2175 doi: 10.1007/s10620-008-0595-1
24
Seong-Eun Kim. Small Intestinal Bacterial OvergrowthIntestinal Research 2010; 8(2): 106 doi: 10.5217/ir.2010.8.2.106
25
Dionysius Subali, Mi Hye Kwon, Won Seok Bang, Hee Eun Kang. The pharmacokinetics of mycophenolic acid in rats with orotic acid induced nonalcoholic fatty liver diseaseCanadian Journal of Physiology and Pharmacology 2020; 98(3): 169 doi: 10.1139/cjpp-2019-0383
26
Ming-Liang Lu, Hua Huang, Li-Ming Liu, Jiang Chang. The Relationship between Intestinal Motility and Interstitial Cells of Cajal in Nonalcoholic Fatty Liver MiceHepatitis Monthly 2013; 13(10) doi: 10.5812/hepatmon.13674
27
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8Digestive Diseases and Sciences 2011; 56(5): 1524 doi: 10.1007/s10620-010-1447-3
28
Han Li, Yin-Ping Wang. Effect of Auricular Acupuncture on Gastrointestinal Motility and Its Relationship with Vagal ActivityAcupuncture in Medicine 2013; 31(1): 57 doi: 10.1136/acupmed-2012-010173
29
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathyCochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
30
Ki Tae Suk, Dong Joon Kim. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver diseaseExpert Review of Gastroenterology & Hepatology 2019; 13(3): 193 doi: 10.1080/17474124.2019.1569513
31
Alessandro Federico, Marcello Dallio, Justyna Godos, Carmela Loguercio, Federico Salomone. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidenceTranslational Research 2016; 167(1): 116 doi: 10.1016/j.trsl.2015.08.002
32
Daisuke Satoh, Takahito Yagi, Takeshi Nagasaka, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Masashi Utsumi, Takehiro Tanaka, Hiroshi Sadamori, Toshiyoshi Fujiwara. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomyWorld Journal of Hepatology 2013; 5(4): 189-195 doi: 10.4254/wjh.v5.i4.189
33
Xin Dai, Huiqin Hou, Wanru Zhang, Tianyu Liu, Yun Li, Sinan Wang, Bangmao Wang, Hailong Cao. Microbial Metabolites: Critical Regulators in NAFLDFrontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.567654
34
Paraskevas Gkolfakis, George Dimitriadis, Konstantinos Triantafyllou. Gut microbiota and non-alcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2015; 14(6): 572 doi: 10.1016/S1499-3872(15)60026-1
35
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and TherapyNutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
36
Toral Manvar, Vijay Lakhujani. Encyclopedia of Bioinformatics and Computational Biology2019; : 200 doi: 10.1016/B978-0-12-809633-8.20503-7
37
Desh Raj, Bhawna Tomar, Amit Lahiri, Shrikant R. Mulay. The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney diseasePharmacological Research 2020; 152: 104617 doi: 10.1016/j.phrs.2019.104617
38
Gakuhei Son, Michael Kremer, Ian N. Hines. Contribution of Gut Bacteria to Liver PathobiologyGastroenterology Research and Practice 2010; 2010: 1 doi: 10.1155/2010/453563
39
Guoliang Dai, Bingting Sun, Lei Wu, Xiaojun Gao, Shanshan Song, Hong Sun, Wenzheng Ju. Comparative pharmacokinetics of three alkaloids in normal and acute hepatitis rats after oral administration of Yanhuanglian total alkaloids extractBiomedical Chromatography 2018; 32(11): e4329 doi: 10.1002/bmc.4329
40
Min Seok Cho, Sang Yeol Kim, Ki Tae Suk, Byung-Yong Kim. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibioticsJournal of Microbiology 2018; 56(12): 855 doi: 10.1007/s12275-018-8346-2
41
Richard G McGee, Anouk Bakens, Kerrie Wiley, Stephen M Riordan, Angela C Webster, Richard G McGee. Cochrane Database of Systematic Reviews2011;  doi: 10.1002/14651858.CD008716.pub2
42
Tetyana V. Koval, Ivan V. Chopey, Mykhaylo M. Hechko, Artur V. Kurakh. NON-ALCOHOLIC FATTY LIVER DISEASE IN THE CONTEXT OF ALTERED GUT MICROBIOTAWiadomości Lekarskie 2021; 74(4): 1007 doi: 10.36740/WLek202104137
43
Yu-Jie Zhang, Sha Li, Ren-You Gan, Tong Zhou, Dong-Ping Xu, Hua-Bin Li. Impacts of Gut Bacteria on Human Health and DiseasesInternational Journal of Molecular Sciences 2015; 16(12): 7493 doi: 10.3390/ijms16047493
44
Binrui Chen, Shuwen Zhu, Lijun Du, Huiqin He, John J. Kim, Ning Dai. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse modelScandinavian Journal of Gastroenterology 2017; 52(10): 1065 doi: 10.1080/00365521.2017.1342141
45
Deepa Rana, Ajay Duseja, Radha K. Dhiman, Yogesh Chawla, Sunil K. Arora. Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxinHepatology International 2013; 7(2): 562 doi: 10.1007/s12072-012-9371-6
46
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Pharmaceuticals from MicrobesEnvironmental Chemistry for a Sustainable World 2019; 28: 207 doi: 10.1007/978-3-030-04675-0_8
47
Haiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectivesJournal of Gastroenterology 2020; 55(2): 142 doi: 10.1007/s00535-019-01649-8